AEPCX | ATGGX | AEPCX / ATGGX | |
Total Expense Ratio | 1.57 | 1.02 | 154% |
Annual Report Gross Expense Ratio | 1.57 | 1.02 | 154% |
Fund Existence | 24 years | 8 years | - |
Gain YTD | 15.502 | 14.848 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 135B | 2.72B | 4,971% |
Annual Yield % from dividends | 0.17 | 0.62 | 27% |
Returns for 1 year | 7.17 | 9.15 | 78% |
Returns for 3 years | 22.17 | 26.23 | 85% |
Returns for 5 years | 8.82 | 4.83 | 183% |
Returns for 10 years | 26.76 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SWHFX | 23.68 | 0.33 | +1.41% |
Schwab Health Care | |||
ITCTX | 25.88 | N/A | N/A |
VY® T. Rowe Price Capital Apprec S2 | |||
WQAIX | 12.19 | -0.03 | -0.25% |
Westwood Quality AllCap Institutional | |||
NWHTX | 33.90 | -0.14 | -0.41% |
Nationwide Bailard Tech & Sci R6 | |||
BMSSX | 14.87 | -0.07 | -0.47% |
MFS Blended Research Mid Cap Eq R2 |